Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bonora

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
The Journal of Infection|June 14, 2008
Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycinsS Bonora, A Mondo, L Trentini, et al.
Le Infezioni in Medicina|August 8, 2006
[Clinical pharmacology of nucleoside and nucleotide reverse transcriptase inhibitors]S Bonora, A Calcagno, D Gonzalez de Requena, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2006
Ritonavir-dependent fluconazole boosting of nelfinavir: a report of three casesS Garazzino, M Tettoni, A Calcagno, et al.
The Review of Scientific Instruments|January 3, 2013
Active diffraction gratings: development and testsS Bonora, F Frassetto, E Zanchetta, et al.
Chest|May 1, 1997
Fatal pneumothorax complicating BAL in a bone marrow transplant recipient with bronchiolitis obliteransA Cazzadori, G Di Perri, S Bonora, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|April 3, 2012
The effect of antituberculosis treatment on interferon-gamma release assay resultsM Bugiani, S Bonora, A Carosso, et al.
The Journal of Infection|November 1, 1996
Cryptococcal dermatitis with negative antigenaemia heralding disseminated disease in HIV infectionF Soldani, M Lanzafame, B Allegranzi, et al.
Optics Letters|April 3, 2008
Sub-two-cycle light pulses at 1.6 microm from an optical parametric amplifierD Brida, G Cirmi, C Manzoni, et al.
Infection|August 15, 2016
HCV NS3 naturally occurring variants in HIV/HCV coinfected DAA-naïve patients: consideration for HCV genotyping resistance testingT Ruggiero, E Burdino, A Calcagno, et al.
The New Microbiologica|January 14, 2005
Clinical pharmacology of antiretroviral therapyG Di Perri, A Sinicco, S Audagnotto, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Infection|June 14, 2008
Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycinsS Bonora, A Mondo, L Trentini, et al.
Le Infezioni in Medicina|August 8, 2006
[Clinical pharmacology of nucleoside and nucleotide reverse transcriptase inhibitors]S Bonora, A Calcagno, D Gonzalez de Requena, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2006
Ritonavir-dependent fluconazole boosting of nelfinavir: a report of three casesS Garazzino, M Tettoni, A Calcagno, et al.
The Review of Scientific Instruments|January 3, 2013
Active diffraction gratings: development and testsS Bonora, F Frassetto, E Zanchetta, et al.
Chest|May 1, 1997
Fatal pneumothorax complicating BAL in a bone marrow transplant recipient with bronchiolitis obliteransA Cazzadori, G Di Perri, S Bonora, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|April 3, 2012
The effect of antituberculosis treatment on interferon-gamma release assay resultsM Bugiani, S Bonora, A Carosso, et al.
The Journal of Infection|November 1, 1996
Cryptococcal dermatitis with negative antigenaemia heralding disseminated disease in HIV infectionF Soldani, M Lanzafame, B Allegranzi, et al.
Optics Letters|April 3, 2008
Sub-two-cycle light pulses at 1.6 microm from an optical parametric amplifierD Brida, G Cirmi, C Manzoni, et al.
Infection|August 15, 2016
HCV NS3 naturally occurring variants in HIV/HCV coinfected DAA-naïve patients: consideration for HCV genotyping resistance testingT Ruggiero, E Burdino, A Calcagno, et al.
The New Microbiologica|January 14, 2005
Clinical pharmacology of antiretroviral therapyG Di Perri, A Sinicco, S Audagnotto, et al.
Pageof 11